Please enable JavaScript to continue using this application.

Compare $CELC vs $RCUS | Chartloom

Compare

$CELC vs $RCUS

Celcuity Inc · Arcus Biosciences Inc

CELC

Celcuity Inc

RCUS

Arcus Biosciences Inc

Compare $CELC vs $RCUS

Comparing Celcuity Inc and Arcus Biosciences Inc

CELCCelcuity Inc

RCUSArcus Biosciences Inc

CELCCelcuity Inc

Market cap

$3.31B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

21.34x

Rev growth (TTM)

—

YTD performance

-32.4%

52W performance

37.3%

FCF yield

-5.8%

RCUSArcus Biosciences Inc

Market cap

$3.07B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

84.08x

Rev growth (TTM)

-55.3%

YTD performance

4.8%

52W performance

62.2%

FCF yield

-15.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CELC

RCUS

Detailed metrics comparison

CELC

Celcuity Inc

RCUS

Arcus Biosciences Inc

Market Cap

CELC$3.31B

RCUS$3.07B

Enterprise Value

CELC$3.88B

RCUS$3.02B

Price

CELC$67.94

RCUS$24.41

P/E Ratio

CELCN/A

RCUSN/A

P/S Ratio

CELC0.00x

RCUS26.24x

EV/Sales

CELC0.00x

RCUS25.82x

EV/EBITDA

CELC0.00x

RCUS37.63x

P/B Ratio

CELC65.91x

RCUS6.71x

P/FCF Ratio

CELCN/A

RCUSN/A

EV/FCF

CELC-20.20x

RCUS-6.36x

PEG Ratio

CELCN/A

RCUSN/A

Forward P/E (NTM)

CELCN/A

RCUSN/A

Forward P/S (NTM)

CELC21.34x

RCUS84.08x

Revenue (TTM)

CELC$0

RCUS$117M

Revenue Growth (YoY)

CELCN/A

RCUS-55.3%

Forward Rev Growth

CELC964.0%

RCUS-34.4%

Gross Margin (TTM)

CELC0.0%

RCUS0.0%

Operating Margin (TTM)

CELC0.0%

RCUS0.0%

EBITDA Margin (TTM)

CELC0.0%

RCUS-406.8%

Net Margin (TTM)

CELC0.0%

RCUS-393.2%

FCF Margin (TTM)

CELCN/A

RCUS-406.0%

Net Income (TTM)

CELC$-226M

RCUS$-460M

FCF (TTM)

CELC$-192M

RCUS$-475M

EPS (TTM)

CELC-$4.13

RCUS-$3.65

ROE (TTM)

CELC-24461.0%

RCUS-8954.0%

ROA (TTM)

CELC-4154.0%

RCUS-4561.0%

ROIC (TTM)

CELC-5590.0%

RCUS-7501.0%

Cash

CELC$182M

RCUS$150M

Debt

CELC$753M

RCUS$101M

Net Cash/Debt

CELC$-571M

RCUS$49M

Current Ratio (TTM)

CELC8.93x

RCUS3.82x

Quick Ratio (TTM)

CELC8.78x

RCUS3.75x

Debt/Equity (TTM)

CELC6.04x

RCUS0.22x

Debt/Assets (TTM)

CELC0.0%

RCUS0.0%

Interest Coverage (TTM)

CELCN/A

RCUSN/A

Net Debt/EBITDA (TTM)

CELC0.00x

RCUS0.00x

Beta

CELC0.11

RCUS1.05

52W Performance

CELC37.3%

RCUS62.2%

YTD Performance

CELC-32.4%

RCUS4.8%

% from 52W High

CELC-55.0%

RCUS-23.1%

% from 52W Low

CELC50.9%

RCUS71.2%

Asset Turnover (TTM)

CELC0.00x

RCUS0.12x

FCF Yield (TTM)

CELC-5.8%

RCUS-15.5%

Earnings Yield (TTM)

CELC-6.8%

RCUS-15.0%

Dividend Yield (TTM)

CELCN/A

RCUSN/A

Rule of 40

CELC0.0

RCUS-461.3

EV/GP/RG

CELCN/A

RCUSN/A

Ticker research

View CELC research View RCUS research

Metric	CELC Celcuity Inc	RCUS Arcus Biosciences Inc
Market & Valuation
Market Cap	$3.31B	$3.07B
Enterprise Value	$3.88B	$3.02B
Price	$67.94	$24.41
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	26.24x
EV/Sales	0.00x	25.82x
EV/EBITDA	0.00x	37.63x
P/B Ratio	65.91x	6.71x
P/FCF Ratio	N/A	N/A
EV/FCF	-20.20x	-6.36x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	21.34x	84.08x
Revenue & Growth
Revenue (TTM)	$0	$117M
Revenue Growth (YoY)	N/A	-55.3%
Forward Rev Growth	964.0%	-34.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-406.8%
Net Margin (TTM)	0.0%	-393.2%
FCF Margin (TTM)	N/A	-406.0%
Net Income (TTM)	$-226M	$-460M
FCF (TTM)	$-192M	$-475M
EPS (TTM)	-$4.13	-$3.65
ROE (TTM)	-24461.0%	-8954.0%
ROA (TTM)	-4154.0%	-4561.0%
ROIC (TTM)	-5590.0%	-7501.0%
Financial Health
Cash	$182M	$150M
Debt	$753M	$101M
Net Cash/Debt	$-571M	$49M
Current Ratio (TTM)	8.93x	3.82x
Quick Ratio (TTM)	8.78x	3.75x
Debt/Equity (TTM)	6.04x	0.22x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.11	1.05
52W Performance	37.3%	62.2%
YTD Performance	-32.4%	4.8%
% from 52W High	-55.0%	-23.1%
% from 52W Low	50.9%	71.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.12x
FCF Yield (TTM)	-5.8%	-15.5%
Earnings Yield (TTM)	-6.8%	-15.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-461.3
EV/GP/RG	N/A	N/A
Ticker research	View CELC research	View RCUS research

Valuation

P/S Ratio

CELC

0.00x

RCUS

26.24x

EV/FCF

CELC

-20.20x

RCUS

-6.36x

Growth & revenue

Revenue Growth TTM

RCUS

-55.3%

Forward Revenue Growth

CELC

964.0%

RCUS

-34.4%

Profitability & performance

Gross Margin

CELC

0.0%

RCUS

0.0%

ROE

RCUS

-8954.0%

CELC

-24461.0%

FCF Yield %

CELC

-5.8%

RCUS

-15.5%

52-Week Performance

RCUS

62.2%

CELC

37.3%

Detailed metrics comparison

CELC

Celcuity Inc

RCUS

Arcus Biosciences Inc

Market Cap

CELC$3.31B

RCUS$3.07B

Enterprise Value

CELC$3.88B

RCUS$3.02B

Price

CELC$67.94

RCUS$24.41

P/E Ratio

CELCN/A

RCUSN/A

P/S Ratio

CELC0.00x

RCUS26.24x

EV/Sales

CELC0.00x

RCUS25.82x

EV/EBITDA

CELC0.00x

RCUS37.63x

P/B Ratio

CELC65.91x

RCUS6.71x

P/FCF Ratio

CELCN/A

RCUSN/A

EV/FCF

CELC-20.20x

RCUS-6.36x

PEG Ratio

CELCN/A

RCUSN/A

Forward P/E (NTM)

CELCN/A

RCUSN/A

Forward P/S (NTM)

CELC21.34x

RCUS84.08x

Revenue (TTM)

CELC$0

RCUS$117M

Revenue Growth (YoY)

CELCN/A

RCUS-55.3%

Forward Rev Growth

CELC964.0%

RCUS-34.4%

Gross Margin (TTM)

CELC0.0%

RCUS0.0%

Operating Margin (TTM)

CELC0.0%

RCUS0.0%

EBITDA Margin (TTM)

CELC0.0%

RCUS-406.8%

Net Margin (TTM)

CELC0.0%

RCUS-393.2%

FCF Margin (TTM)

CELCN/A

RCUS-406.0%

Net Income (TTM)

CELC$-226M

RCUS$-460M

FCF (TTM)

CELC$-192M

RCUS$-475M

EPS (TTM)

CELC-$4.13

RCUS-$3.65

ROE (TTM)

CELC-24461.0%

RCUS-8954.0%

ROA (TTM)

CELC-4154.0%

RCUS-4561.0%

ROIC (TTM)

CELC-5590.0%

RCUS-7501.0%

Cash

CELC$182M

RCUS$150M

Debt

CELC$753M

RCUS$101M

Net Cash/Debt

CELC$-571M

RCUS$49M

Current Ratio (TTM)

CELC8.93x

RCUS3.82x

Quick Ratio (TTM)

CELC8.78x

RCUS3.75x

Debt/Equity (TTM)

CELC6.04x

RCUS0.22x

Debt/Assets (TTM)

CELC0.0%

RCUS0.0%

Interest Coverage (TTM)

CELCN/A

RCUSN/A

Net Debt/EBITDA (TTM)

CELC0.00x

RCUS0.00x

Beta

CELC0.11

RCUS1.05

52W Performance

CELC37.3%

RCUS62.2%

YTD Performance

CELC-32.4%

RCUS4.8%

% from 52W High

CELC-55.0%

RCUS-23.1%

% from 52W Low

CELC50.9%

RCUS71.2%

Asset Turnover (TTM)

CELC0.00x

RCUS0.12x

FCF Yield (TTM)

CELC-5.8%

RCUS-15.5%

Earnings Yield (TTM)

CELC-6.8%

RCUS-15.0%

Dividend Yield (TTM)

CELCN/A

RCUSN/A

Rule of 40

CELC0.0

RCUS-461.3

EV/GP/RG

CELCN/A

RCUSN/A

Ticker research

View CELC research View RCUS research

Metric	CELC Celcuity Inc	RCUS Arcus Biosciences Inc
Market & Valuation
Market Cap	$3.31B	$3.07B
Enterprise Value	$3.88B	$3.02B
Price	$67.94	$24.41
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	26.24x
EV/Sales	0.00x	25.82x
EV/EBITDA	0.00x	37.63x
P/B Ratio	65.91x	6.71x
P/FCF Ratio	N/A	N/A
EV/FCF	-20.20x	-6.36x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	21.34x	84.08x
Revenue & Growth
Revenue (TTM)	$0	$117M
Revenue Growth (YoY)	N/A	-55.3%
Forward Rev Growth	964.0%	-34.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-406.8%
Net Margin (TTM)	0.0%	-393.2%
FCF Margin (TTM)	N/A	-406.0%
Net Income (TTM)	$-226M	$-460M
FCF (TTM)	$-192M	$-475M
EPS (TTM)	-$4.13	-$3.65
ROE (TTM)	-24461.0%	-8954.0%
ROA (TTM)	-4154.0%	-4561.0%
ROIC (TTM)	-5590.0%	-7501.0%
Financial Health
Cash	$182M	$150M
Debt	$753M	$101M
Net Cash/Debt	$-571M	$49M
Current Ratio (TTM)	8.93x	3.82x
Quick Ratio (TTM)	8.78x	3.75x
Debt/Equity (TTM)	6.04x	0.22x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.11	1.05
52W Performance	37.3%	62.2%
YTD Performance	-32.4%	4.8%
% from 52W High	-55.0%	-23.1%
% from 52W Low	50.9%	71.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.12x
FCF Yield (TTM)	-5.8%	-15.5%
Earnings Yield (TTM)	-6.8%	-15.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-461.3
EV/GP/RG	N/A	N/A
Ticker research	View CELC research	View RCUS research